Salesforce analysts view on earnings tonight:

Salesforce Reports Tonight: Reading the Options Tape Ahead of Q2 FY2027 — Muffett Investments Research Note
MUFFETT INVESTMENTS
RESEARCH NOTE — ENTERPRISE SOFTWARE / AI PLATFORMISATION & THE Q2 FY2027 EARNINGS EVENT
NYSE: CRM  •  AVG ANALYST TARGET $242.64  •  REPORTS TODAY, AUGUST 26 2026, AFTER MARKET CLOSE

Salesforce Reports Tonight: What Wall Street Expects and What the Options Market Is Pricing In

Consensus calls for $11.32B in revenue and $3.27 in non-GAAP EPS, but management's own guidance leaves almost no cushion above the midpoint. Options are pricing a ~7–8% swing — more than double the stock's trailing four-quarter average move — as Agentforce's $1.2B ARR run-rate collides with a stock trading at its cheapest multiple in five years.
Consensus Revenue
$11.32B
Options Implied Move
~7–8%
Avg Price Target
$242.64
Fwd P/E (5-Yr Low)
14.7x
Rating
BUY
August 26, 2026  •  Prepared by Muffett Investments  •  Sources: NotebookLM Deep Research (128 sources synthesized across three research passes, including a dedicated Slide Deck output), TipRanks, Benzinga, Barchart, Yahoo Finance, stockanalysis.com, GuruFocus, Salesforce Investor Relations, Bullfincher geographic revenue data
Salesforce reports fiscal Q2 2027 results after the closing bell tonight, and the setup is unusually two-sided for a stock that has beaten EPS in nine of its last ten quarters. The bull case rests on Agentforce's consumption-priced AI agents crossing a genuine $1.2 billion annual-recurring-revenue run-rate (+205% year-over-year) at record 34.8% non-GAAP operating margins, while the stock itself trades near a five-year-low forward earnings multiple after a roughly 20% year-to-date drawdown. The complication is that management's own revenue guidance range leaves consensus almost no room to beat, underlying organic growth (stripped of the Informatica acquisition) is estimated at only 6-9% against the 13% headline, and the stock has actually fallen the day after five of its last eight earnings reports despite beating EPS in nine of the last ten. Tonight's print, and more specifically the quality of the cRPO number and Agentforce commentary, will decide which story wins.

1  Executive Setup: Tonight's Print

Salesforce closed regular trading on August 25 at $207.11, roughly 20-22% below its 52-week high, even as the underlying AI story has strengthened every quarter this year. That combination — a compressing multiple against an accelerating product cycle — is exactly the setup Muffett Investments looks for: a name where price and fundamentals have disconnected, and where a single earnings print can force the market to reconcile the two. Tonight's fiscal Q2 2027 report (for the quarter ended July 31, 2026) is that reconciliation event.

The headline numbers themselves are unlikely to be the swing factor. Consensus revenue of $11.32 billion sits almost exactly at the midpoint of management's own $11.27–$11.35 billion guidance range, and consensus non-GAAP EPS of $3.27 implies a comfortable 12.4% year-over-year increase consistent with Salesforce's recent beat cadence. The real battleground is quality of growth: how much of the 13%+ headline growth is organic versus inherited from the Informatica acquisition, whether contracted-but-unrecognized revenue (cRPO) reaccelerates toward the 13-14% analysts are modeling, and whether Agentforce adoption is translating from pilot enthusiasm into the kind of durable, consumption-based revenue that justifies re-rating the stock higher.

2  What Wall Street Expects: Consensus vs. Guidance

Salesforce's own guidance leaves the Street unusually little margin for a clean "beat." Consensus revenue is just $10 million — about nine basis points — above the midpoint of management's guided range, which puts far more weight on subscription mix, cRPO, and margin quality than on the topline print itself.

Metric Q2 FY2027 Consensus Q2 FY2026 (Year-Ago Actual) Implied YoY Growth
Total Revenue $11.32B – $11.33B $10.24B +10.6% – 11.0%
Management Revenue Guidance $11.27B – $11.35B Consensus sits at midpoint
Non-GAAP EPS $3.27 $2.91 +12.4%
GAAP EPS ~$2.35 ~$2.27 +3.5%
Subscription & Support Revenue $10.78B ~$9.69B +11.3%
Current RPO (cRPO) $33.31B (est.), 13–14% growth modeled $29.40B +13.3%
Total RPO $67.69B $59.90B +13.0%
Non-GAAP EPS Guidance $3.25 – $3.27 Consensus sits at top of range
FY2027 Full-Year Revenue Guidance $45.9B – $46.2B Reaffirmation is the base case
Muffett Lens: The number that matters most tonight is cRPO, not revenue. Revenue is already effectively pre-announced by guidance; cRPO growth is the market's read on forward demand, and it is the metric most directly tied to whether Agentforce and Data Cloud bookings are compounding or merely holding steady. Oppenheimer's Brian Schwartz has flagged 13-14% cRPO growth in the following quarter as the number that could support a broader revenue reacceleration narrative — that is the print within the print. NotebookLM's synthesis of the estimate landscape flags the same tension from a different angle: ex-Informatica organic growth is now running closer to 6-7%, well below the 10-11% headline — making the "upside to cRPO guidance" the definitive metric required to prove true bookings momentum rather than acquisition-driven mix.

3  The Options Market: Pricing a ~7–8% Swing

Options market pricing for tonight's event is unusually wide for a name of Salesforce's size and predictability, and — notably — the directional positioning is genuinely split across data providers, which is itself a signal that the market has no strong consensus on which way this resolves.

IMPLIED TRADING BAND FOR TONIGHT'S EARNINGS REACTION LOWER BOUND ~$189.00 cRPO miss / "trials not conversions" narrative SPOT PRICE (8/25-26) ~$206 20-22% below 52-wk high 14.7x forward earnings UPPER BOUND ~$223.00 cRPO beat + durable Agentforce commentary
Options-implied trading band for the session following tonight's release, per NotebookLM's dedicated Deep Research pass on Salesforce options pricing (37 sources): a straddle-derived implied move of ±8.01% for the August 28 expiry against a spot near $205.69, producing an implied band of roughly $189.00 to $223.00. That represents close to $12 billion of market capitalization in play in either direction — more than double the stock's trailing four-quarter average post-earnings move of 3.33%.
Options Signal Reading Interpretation
Straddle-derived implied move (Aug 28 exp.) ±8.01% More than double the 3.33% trailing four-quarter average realized move
Implied trading band $189.00 – $223.00 ~$12B of market capitalization in play around a ~$206 spot
Put-to-call ratio (Aug 28 exp., NotebookLM synthesis) 0.85x Below 1.0x — book leans toward an upward resolution
Earlier near-term put/call snapshot (secondary source) 1.06x A different intraday snapshot skewed bearish — readings have moved as the print approached
Muffett Lens: An 8.01% implied move against a 3.33% trailing average is the market explicitly telling you this is not a formality — it is pricing a legitimate binary-ish event. The put/call positioning has shifted as the session progressed (an earlier snapshot showed a bearish 1.06x skew; NotebookLM's synthesis of the most current options-flow data puts it at a bullish-leaning 0.85x), which itself tells you the book stayed genuinely two-sided into the print rather than settling on a consensus direction. That is consistent with a name whose valuation has been reset lower even as its highest-margin product line accelerates — the options market is pricing real uncertainty about which narrative wins, not a foregone conclusion.

4  Historical Earnings-Day Track Record

Salesforce's post-earnings reaction history complicates the simple "beat and it rallies" playbook. NotebookLM's synthesis of the last ten quarters shows Salesforce beating consensus revenue estimates in seven of ten quarters (including the last two straight) and beating EPS estimates in nine of ten quarters (including the last six straight) — a genuinely strong execution record. Yet the stock's actual day-after price reaction has been far less consistent: it has traded lower the day following five of its last eight quarterly reports, including a roughly 3% drop after its most recent quarter despite beating estimates. In other words, beating consensus has not been a reliable predictor of a positive stock reaction; the market has repeatedly focused on forward guidance, cRPO quality, and margin trajectory over the headline beat itself.

Against that backdrop, the trailing four-quarter average post-earnings move has been a relatively modest 3.33% in either direction — which makes tonight's 8.01% implied move especially notable, more than double the historical norm. The options market is explicitly pricing a larger-than-typical reaction, consistent with a setup where (a) the stock has run up sharply into the print (+18.5% to +30.9% over the trailing month across different measurement windows), pushing RSI into overbought territory in the mid-60s, and (b) the market genuinely does not know whether tonight resolves the "is Agentforce real revenue or acquisition-driven mix" debate in the bulls' or bears' favor.

Muffett Lens: A stock that beats EPS in nine of its last ten quarters but still falls more often than not the next day is a stock where the market has already moved past "did they beat" and is pricing "did the story get better." That is precisely the dynamic we look for — it means a genuinely strong Agentforce/cRPO print tonight has real re-rating power, because the bar the market is actually testing is higher than the consensus numbers alone suggest.

5  Agentforce & Data Cloud: The AI Monetization Scorecard

The single most important debate heading into tonight's print is whether Agentforce — Salesforce's consumption-priced AI agent platform — has crossed from pilot enthusiasm into durable, compounding revenue. The Q1 FY2027 data points were the strongest evidence yet that it has:

AGENTFORCE (Q1 FY27 ACTUAL) • ARR: $1.2 billion (+205% YoY) • 3.8B Agentic Work Units delivered • 28.6T tokens processed (cumulative) CONSUMPTION PRICING: $2+/CONVERSATION COMBINED AI + DATA CLOUD • Combined ARR: $3.4B (+200%+ YoY) • Non-GAAP op. margin: 34.8% (record) • FY27 op. margin guide: 34.3% SCALING WITHOUT MARGIN DILUTION
Agentforce's Q1 FY2027 metrics (reported May 2026): consumption-based pricing decouples AI revenue from seat-based licensing constraints, and management reported this scaling alongside a record 34.8% non-GAAP operating margin rather than at its expense. Tonight's report is the first full quarter to test whether this trajectory is continuing at a similar or accelerating rate.

The bear counterpoint, addressed directly in Section 10, is that Agentforce's growth rate is measured off a small base and that combined AI/Data Cloud ARR of $3.4 billion is still under 8% of total revenue — meaningful, but not yet large enough on its own to move the headline growth rate. Tonight's print is the first real test of whether the Q1 acceleration was a step-change or a one-quarter high-water mark.

Agentforce actually monetizes through two distinct mechanisms, and the mix between them is itself a signal worth watching. "Flex Credits" are a pay-per-action model — $500 per 100,000 credits, with each action consuming 20 credits (roughly $0.10 per action), and a base tier of 100,000 free credits bundled into Enterprise and Foundations editions — aimed at micro-transaction workflow automation. "Conversations" are priced at a flat $2.00 per full conversation, positioned for complete end-to-end case resolutions that replace human touchpoints entirely. Encouragingly, NotebookLM's research indicates roughly 50% of all AI bookings are now generated from cross-selling existing customers rather than net-new logos — a sign the platform is expanding within the installed base rather than relying solely on new-customer acquisition. The data foundation underpinning this is itself M&A-fueled: the $8 billion Informatica acquisition (enterprise data integration and governance) and the $430 million Zoomin acquisition (proprietary unstructured data unification) both feed directly into Data Cloud and the Einstein Trust Layer that make Agentforce's outputs enterprise-grade.

6  The AI Platformisation Megatrend & the Developing-World Multiplier

Salesforce sits squarely inside the AI platformisation megatrend — enterprise software and cloud infrastructure re-architecting itself around agentic AI rather than seat-based licensing — and it is one of the few enterprise software incumbents with both the customer data moat (Data Cloud) and the distribution (19+ years of CRM relationships across the Fortune 500) to monetize that shift rather than be disrupted by it.

The company's international mix also still carries a meaningful growth-runway argument, even though Salesforce is a mature, developed-market-weighted franchise rather than a classic emerging-markets story:

Region Share of FY2026 Revenue YoY Growth Rate
Americas 65.5% ($27.19B) +8.15%
Europe 24.1% ($10.02B) +12.66% (fastest-growing region)
Asia Pacific 10.4% ($4.32B) +11.76%
Muffett Lens: Both Europe and Asia Pacific are growing faster than the mature Americas base and are steadily taking share of the revenue mix (Americas has slipped from 66.8% in FY2024 to 65.5% today). Asia Pacific in particular remains under-penetrated at just 10.4% of revenue against a much larger share of global GDP and enterprise software spend growth — that gap is a multi-year tailwind rather than a one-quarter catalyst, and it compounds on top of, not instead of, the Agentforce re-rating story.

7  Valuation vs. Own History: A Five-Year Low

The most important number in this entire report may not be an earnings estimate at all — it is the multiple the market is currently willing to pay for Salesforce's earnings, measured against its own trading history rather than against peers.

Fiscal Year Forward P/E vs. Current (14.7x)
2022 48.08x 3.3x higher
2023 29.33x 2.0x higher
2024 29.24x 2.0x higher
2025 29.91x 2.0x higher
2026 (Current) 14.7x – 16.2x Multi-year low

A forward multiple in the mid-teens is roughly half of where Salesforce traded for most of the 2022-2025 period, despite non-GAAP operating margin having expanded to a record 34.8% and Agentforce now contributing a genuine, fast-growing revenue stream that did not exist three years ago. Some of that compression is fair — the broader software multiple de-rating since 2022 was real, and CRM's own current forward P/E of 14.7x sits roughly 25% below the software industry median of ~19.6x, per GuruFocus. But the magnitude of the gap between Salesforce's own trading history and its current multiple, set against improving (not deteriorating) fundamentals, is the core of the valuation argument here.

Muffett Lens: This is a classic "passive-driven, price-disconnected-from-fundamentals" setup. A stock trading at less than half its own five-year average multiple, with margins at record highs and a genuine new AI revenue line scaling at triple-digit growth, is not a broken business — it is a re-rating candidate waiting for a catalyst. We are not afraid of near-term drawdown here if tonight's print disappoints; a further sell-off on a "quality of growth" complaint rather than a fundamental deterioration would make us more interested, not less. Start with a nibble into the print and add on confirmation of cRPO strength or Agentforce durability.

The free-cash-flow trajectory gives the valuation argument a second leg. NotebookLM's synthesis projects free cash flow expanding from $14.4 billion in FY2026 to $20.5 billion by FY2031, growing in roughly $1.2-1.8 billion annual steps. Against that trajectory, the stock currently trades at approximately 12x calendar-2027 FCF for a 9% FCF yield — flagged in the research as the most undervalued major peer in its software sector on this basis. Management has also drawn an explicit floor under the stock with a $27.5 billion accelerated share repurchase program (funded by $25 billion of debt issuance), on top of a 0.84% dividend yield. That combination — a cheap multiple on a growing cash-flow base, backstopped by one of the largest buybacks in software history — is precisely the kind of asymmetry Muffett Investments looks for: the downside is cushioned by the buyback floor even if tonight's print merely meets expectations, while the upside is uncapped if it exceeds them.

8  Analyst Ratings & Price Targets

WALL STREET CONSENSUS (53 ANALYSTS, STOCKANALYSIS.COM) STRONG BUY + BUY 38 / 53 72% of coverage Overall Rating: BUY HOLD 13 / 53 25% of coverage Incl. Zacks Rank #3 SELL 2 / 53 4% of coverage No Strong Sell ratings TARGET RANGE $160 – $475 Avg $242.64 / Med $236 +17.96% avg upside
Analyst positioning heading into tonight's print: 53 covering analysts per stockanalysis.com skew heavily toward Buy (38 of 53, or 72%), with an average price target of $242.64 (roughly 18% above the August 25 close). TipRanks' narrower trailing-three-month sample (36 analysts) shows a similar "Moderate Buy" skew with a $238.94 average target.
Firm / Analyst Rating Price Target
Oppenheimer (Brian Schwartz) Buy $250
Cantor Fitzgerald (Matthew VanVliet) Overweight $250
JPMorgan Overweight $250
Wall Street Consensus (stockanalysis.com, 53 analysts) Buy Avg $242.64 / Median $236
Wall Street Consensus (TipRanks, trailing 3-mo, 36 analysts) Moderate Buy Avg $238.94
Wall Street Consensus (NotebookLM synthesis) Buy (33 Strong Buy / 2 Buy / 16 Hold / 2 Sell) Avg $252.29 (+16% upside)
Zacks Rank #3 — Hold

Different aggregators land on slightly different average targets ($238.94 to $252.29) depending on the exact sample and window of analysts included, but the shape of the distribution is consistent across all of them: a large majority Buy-rated, a meaningful Hold contingent (16-25% of coverage) reflecting the organic-growth debate, and only a small handful of outright Sells. NotebookLM's own sentiment gauge, built from its options-flow research, characterizes the setup as "leaning bullish" — consistent with a book where the bar is high but the risk/reward skews favorably.

9  The Bull Case

  • Valuation reset ahead of an improving business: 14.7x forward earnings is roughly half the stock's 2022-2025 average multiple, despite record margins and a new, fast-growing AI revenue line.
  • Agentforce is real, measurable revenue: $1.2 billion ARR at +205% YoY, on consumption-based pricing that decouples growth from seat-count constraints — this is a fundamentally different monetization model than Salesforce's historical per-seat licensing.
  • Margins are expanding, not eroding, as AI scales: Record 34.8% non-GAAP operating margin in Q1 FY2027, with FY2027 guidance of 34.3%, directly rebuts the bear thesis that AI product investment would compress profitability.
  • Aggressive capital return: A $27.5 billion accelerated share repurchase program (funded by $25 billion of debt issuance) has already reduced the diluted share count by 99 million shares over the trailing year, on top of a 0.84% dividend yield — a structural EPS tailwind independent of the operating story.
  • Cheap on cash flow, not just earnings: Free cash flow is projected to expand from $14.4 billion (FY2026) to $20.5 billion (FY2031); at roughly 12x calendar-2027 FCF for a 9% yield, NotebookLM's research flags Salesforce as the most undervalued major peer in its sector on this basis.
  • Sentiment and prediction markets lean bullish: Prediction-market venue Polymarket assigned a 91% probability to another earnings beat heading into tonight's print, and the stock has beaten EPS in nine of its last ten quarters.
  • International growth runway intact: Europe (+12.66% YoY) and Asia Pacific (+11.76% YoY) are both outgrowing the mature Americas base (+8.15%) and gaining share of the revenue mix.

10  The Bear Case & Key Risks

  • Organic growth is softer than the headline suggests: Estimates of Q1 revenue growth excluding the Informatica acquisition range from roughly 6-7% (NotebookLM synthesis) to 8.7% (independent analyst estimate), well below the reported 13.3% headline figure — the core debate tonight is whether that organic rate is stabilizing or still decelerating.
  • Data readiness is a real bottleneck, not just a talking point: KeyBanc channel checks quote customers directly: "Customers' data is not organized enough to do meaningful AI work." Separately, TechRadar's reporting indicates implementation partners are struggling to convert Agentforce proof-of-concepts into actual, monetizable pipeline deals — new-business sales cycles are lengthening even as AI hype in the broader market intensifies.
  • Thin guidance cushion: Consensus revenue sits just $10 million above the midpoint of management's own guidance range, leaving little room for a genuine beat-and-raise without unusually strong execution.
  • cRPO miss is the single biggest swing risk: If contracted-but-unrecognized revenue growth disappoints, or if Agentforce commentary reads as "trials and pilots" rather than converting bookings, the stock's history of falling on "good enough" beats (five of the last eight quarters) argues for caution.
  • Macro softness in core product lines: NotebookLM's research flags ongoing renewal softness and budget compression identified specifically across the Marketing, Commerce, and Tableau product lines — a reminder that the AI story sits alongside real softness elsewhere in the portfolio.
  • The structural cannibalization risk to per-seat pricing: A warning attributed to a Parnassus CIO captures the sharpest long-run bear case: as AI agents automate manual tasks and resolve cases autonomously, enterprises may need fewer human agents — posing an existential, structural threat to Salesforce's historical per-seat licensing model, the same model still generating the bulk of today's revenue.
  • AI-native disruptors are emerging: Agile, AI-native competitors such as Sierra and Decagon are bypassing complex CRM integrations entirely, offering faster and simpler enterprise AI agent deployments — a distribution-model threat distinct from Salesforce's traditional competitive set.
  • Small base, big growth-rate optics: Combined AI and Data Cloud ARR of $3.4 billion is still under 8% of total revenue — the eye-catching 200%+ growth rate is partly a function of a small starting base, and its ability to move the consolidated growth rate materially is not yet proven at scale.
  • Technical setup into the print is stretched: The stock is up 18.5% to 30.9% over the trailing month depending on the measurement window, with RSI in the mid-60s (overbought territory) — a level from which even a solid beat can trigger "sell the news."
  • Not unanimous on the Street: A Zacks Rank of #3 (Hold) and 2 outright Sell ratings among the coverage universe are reminders that this is a contested name, not a consensus slam dunk.

11  What To Watch On Tonight's Call

Salesforce's call is scheduled for 5:00 PM ET tonight, shortly after the release crosses. NotebookLM's synthesis distills the debate into three checklist items management commentary needs to address directly:

  • Bookings composition — NNAOV vs. AOV: Does management indicate that new-customer business (Net New Average Order Value) is actually flowing through to the forward revenue base to support aggressive second-half targets, or is growth still leaning on existing-account expansion alone?
  • Agentforce conversion — free to paid: Listen specifically for updates on the conversion of the foundational 100,000 free Flex Credits into the highly monetizable $2.00 paid "Conversations" tier — that conversion rate is the cleanest read on whether Agentforce adoption is genuinely commercial or still pilot-stage.
  • Seat retention and macro tone: Assess management's specific commentary on IT budgets and the resilience of core CRM per-seat renewals amid increasing AI deployment — this is the front line of the structural cannibalization risk discussed in Section 10.
  • Current RPO (cRPO) growth rate: A print at or above the 13-14% range analysts are modeling would be the clearest signal that forward demand is reaccelerating, not just holding steady on acquisition math.
  • FY2027 full-year guidance revision: Any change to the 34.3% non-GAAP operating margin target or the $45.9-$46.2 billion full-year revenue guidance, which would reset the multiple debate directly.
  • Data Cloud attach and token/Agentic Work Unit growth: A sequential update on the 3.8 billion Agentic Work Units (+111% QoQ) and 28.6 trillion cumulative tokens processed (+152% QoQ) would show whether platform usage is compounding.

12  Muffett's Take & Rating Verdict

Salesforce tonight is less a story about whether the company beats consensus — on the historical base rate, it probably does — and more a story about whether the market finally rewards it for doing so. A stock trading at roughly half its own five-year average earnings multiple, generating record operating margins, and scaling a genuinely new, high-growth, consumption-priced AI revenue line is not a business in decline; it is a business the market has not yet decided to believe. The options market's unusually wide, genuinely two-sided implied move captures that tension precisely.

We do not need tonight's print to be perfect to like this setup. A cRPO number in the 13-14% range and Agentforce commentary that shows real production conversion, not just pilot enthusiasm, would be sufficient to start closing the valuation gap described in Section 7. And because the downside case here is "quality of growth disappoints, multiple stays compressed" rather than "the business is broken," we are comfortable treating any post-print weakness as an opportunity to add rather than a reason to walk away. NotebookLM's own synthesis reaches a similar conclusion from the numbers alone: the bar is astronomically high for Agentforce execution, but a 12x free-cash-flow multiple and a $27.5 billion buyback severely limit realistic downside.

RATING: BUY — AI PLATFORMISATION LEADER TRADING AT A FIVE-YEAR VALUATION LOW INTO A GENUINE CATALYST

Salesforce enters tonight's Q2 FY2027 print at 14.7x forward earnings and roughly 12x calendar-2027 free cash flow — both near five-year lows — while Agentforce's consumption-priced AI revenue scales past a $1.2 billion ARR run-rate at 205% growth and record 34.8% operating margins, with roughly half of AI bookings now coming from cross-selling the existing base. Options are pricing an 8.01% swing, more than double the 3.33% trailing realized average, reflecting genuine two-sided uncertainty over cRPO quality and organic growth ex-Informatica rather than a settled bear or bull consensus. With the large majority of the analyst coverage universe at Buy or Strong Buy and average targets spanning $238.94 to $252.29 (14-16% upside from the ~$206 pre-print level), and a $27.5 billion buyback establishing a real valuation floor, we rate CRM a BUY: start with a nibble ahead of the print, and treat any post-earnings weakness driven by "quality of growth" concerns — rather than a fundamental deterioration — as an opportunity to add.

Disclosure: This report reflects the analytical framework and opinions of Muffett Investments as of August 26, 2026, and incorporates consensus estimates, options market data, and analyst commentary researched via a NotebookLM (Gemini Notebook) workflow — two Deep Research passes (earnings expectations, then options positioning) synthesized into a 128-source notebook, deepened with targeted chat queries on historical earnings-day moves and beat/miss records, and consolidated into a 15-slide Studio Slide Deck ("Salesforce (CRM) Q2 FY2027 Earnings Preview: Navigating the Agentic Pivot") — supplemented with direct research from TipRanks, Benzinga, Barchart/Yahoo Finance, stockanalysis.com, GuruFocus, ts2.tech, KeyBanc, TechRadar, and Salesforce's own Q1 FY2027 and Q4 FY2026 investor disclosures. The underlying NotebookLM notebook persists in the author's account for further exploration of sources and slides. Market pricing, options-implied moves, and analyst price targets are approximate as of August 25-26, 2026, change continuously, and figures cited from different data providers may reflect different snapshot times during the trading day. This report is provided for informational purposes only, does not constitute investment advice, and should not be relied upon as the sole basis for any investment decision. Options and event-driven strategies carry substantial risk of loss. Past earnings-reaction performance is not indicative of future results.
Next
Next

Crack spreads and Why Cenovus is the good stock for inflation protection: